Nasdaq

Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.

IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from ...
Yahoo Finance

Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry

IRVINE, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients ...
Nasdaq

Inari Medical Announces Presentation of Positive Chronic Clot Subanalysis Results from Real World CLOUT Registry at LINC 2021

IRVINE, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives ...
Benzinga.com

FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious

The ClotTriever XL Catheter is used to remove clots (thrombi) and blockages (emboli) from large blood vessels (10 to 28 mm) outside the heart, including the second-largest vein in the body, the vena ...
MD&M East

Six Deaths Connected to Inari ClotTriever XL Recall

Inari Medical, on July 19, sent customers an Urgent Medical Device Labeling Correction Letter regarding updates for its ClotTriever XL catheter instructions for use (IFU) after “discovering serious ...